Participants
prostate cancer
PROSTATE CANCER
We included five urologic surgeons who practiced at a participating clinic and routinely discussed management options for low‐risk prostate cancer with patients.We included English‐speaking adult patients scheduled to visit a participating urologic surgeon to discuss a new diagnosis of low‐risk prostate cancer. Eligible patients had at least one of the following: (1) a Gleason score of 6 or 7 (3 + 4); (2) a prostate‐specific antigen level less than 10 ng/mL; (3) a surgeon's referral for study eligibility. We excluded patients unable to give informed consent due to cognitive or emotional barriers and those discussing recurrent or ongoing prostate cancer management. A research coordinator screened potentially eligible patients based on inclusion criteria and confirmed eligibility with the surgeon before arranging to contact the patient to gain consent to enrol in the study; surgeons could also refer patients directly to the study if they used the intervention with a patient during clinical care.